Vaginal Clindamycin Cream Plus Vaginal Probiotic for Bacterial Vaginosis

Bacterial Vaginosis Treatment Clinical Trial

Official title:

Continuous Versus Interrupted Use.of Vaginal Probiotic Plus Vaginal Clindamycin Cream for Bacterial Vaginosis a Randomized Controlled Study

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03234517
• Other study ID #: zuh- 8
• Status: Recruiting
• Phase: Phase 2
• Start date: August 1, 2016
• Est. completion date: August 2018

Study information

• Verified date: July 2017
• Source: Zagazig University
• Contact: Ibrahim A EL sharkwy
• Phone: 00966554818576
• Email: ibrahimsharkwy[@]yahoo.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Vaginal Clindamycin Cream Plus Vaginal probiotic for treatment of Bacterial Vaginosis

Description:

Vaginal Clindamycin Cream was used initially for treatment of Bacterial Vaginosis followed by Vaginal probiotic either in cnotinous or interrupted manner, then assessment of the results of treatment at different time intervals was done.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 200
• Est. completion date: August 2018
• Est. primary completion date: August 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria:

• more than 18 years

• has recurrent Bacterial Vaginosis

Exclusion Criteria:

• pregnancy

• use of other antmicrobial

• not provide informed consent

Related Conditions & MeSH terms

• Bacterial Vaginosis Treatment
• Vaginal Diseases
• Vaginosis, Bacterial

Intervention

Drug:
• Vaginal Clindamycin Cream
Vaginal Clindamycin Cream
• Vaginal Probiotic
Vaginal Probiotic

Locations

Country	Name	City	State
Egypt	Zagazig University	Zagazig

Sponsors (1)

Lead Sponsor	Collaborator
Zagazig University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	initial cure rate	number of women completely cured	2 months
Secondary	recurrence rate	number of women had recurrence	4,6,8and12 months